These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8360820)

  • 1. Percutaneous absorption: a single-layer model.
    Kubota K; Sznitowska M; Maibach HI
    J Pharm Sci; 1993 May; 82(5):450-6. PubMed ID: 8360820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of viable skin layers in percutaneous permeation and its implication in mathematical models: theoretical consideration based on parameters for betamethasone 17-valerate.
    Kubota K; Maibach HI
    J Pharm Sci; 1994 Sep; 83(9):1300-6. PubMed ID: 7830247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro percutaneous permeation of betamethasone and betamethasone 17-valerate.
    Kubota K; Maibach HI
    J Pharm Sci; 1993 Oct; 82(10):1039-45. PubMed ID: 8254489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model analysis of flux enhancement across hairless mouse skin induced by chemical permeation enhancers.
    He N; Warner KS; Higuchi WI; Li SK
    Int J Pharm; 2005 Jun; 297(1-2):9-21. PubMed ID: 15907593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion modeling of percutaneous absorption kinetics: 3. Variable diffusion and partition coefficients, consequences for stratum corneum depth profiles and desorption kinetics.
    Anissimov YG; Roberts MS
    J Pharm Sci; 2004 Feb; 93(2):470-87. PubMed ID: 14705203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles.
    Zhang J; Smith E
    J Pharm Sci; 2011 Mar; 100(3):896-903. PubMed ID: 20839362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous permeation of basic compounds through shed snake skin as a model membrane.
    Takahashi K; Tamagawa S; Katagi T; Rytting JH; Nishihata T; Mizuno N
    J Pharm Pharmacol; 1993 Oct; 45(10):882-6. PubMed ID: 7904627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous absorption of benzoic acid across human skin. I. In vitro experiments and mathematical modeling.
    Parry GE; Bunge AL; Silcox GD; Pershing LK; Pershing DW
    Pharm Res; 1990 Mar; 7(3):230-6. PubMed ID: 2339094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous diffusion and metabolism of betamethasone 17-valerate in the living skin equivalent.
    Kubota K; Ademola J; Maibach HI
    J Pharm Sci; 1995 Dec; 84(12):1478-81. PubMed ID: 8748331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vehicle properties on skin penetration of emedastine.
    Harada S; Takahashi Y; Nakagawa H; Yamashita F; Hashida M
    Biol Pharm Bull; 2000 Oct; 23(10):1224-8. PubMed ID: 11041256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo.
    Pershing LK; Lambert LD; Knutson K
    Pharm Res; 1990 Feb; 7(2):170-5. PubMed ID: 2308897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-permeability relationship analysis of the permeation barrier properties of the stratum corneum and viable epidermis/dermis of rat skin.
    Yamaguchi K; Mitsui T; Aso Y; Sugibayashi K
    J Pharm Sci; 2008 Oct; 97(10):4391-403. PubMed ID: 18228598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo percutaneous absorption: a key role for stratum corneum/vehicle partitioning.
    Rougier A; Rallis M; Krien P; Lotte C
    Arch Dermatol Res; 1990; 282(8):498-505. PubMed ID: 2128017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17beta-estradiol matrixpatch removal and reapplication in postmenopausal women: theoretical predictions with an oscillating diffusion coefficient model.
    Rohr UD; Saeger-Lorenz K
    J Pharm Sci; 2002 Mar; 91(3):822-44. PubMed ID: 11920768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of steady-state skin permeabilities of polar and nonpolar permeants across excised pig skin based on measurements of transient diffusion: characterization of hydration effects on the skin porous pathway.
    Tang H; Blankschtein D; Langer R
    J Pharm Sci; 2002 Aug; 91(8):1891-907. PubMed ID: 12115816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of skin thickness on the in vitro permeabilities of drugs through Sprague-Dawley rat or Yucatan micropig skin.
    Takeuchi H; Ishida M; Furuya A; Todo H; Urano H; Sugibayashi K
    Biol Pharm Bull; 2012; 35(2):192-202. PubMed ID: 22293349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of physicochemical properties of cyclic terpenes on their ex vivo skin absorption and elimination kinetics.
    Cal K; Kupiec K; Sznitowska M
    J Dermatol Sci; 2006 Feb; 41(2):137-42. PubMed ID: 16260121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous absorption of steroids: relative contributions of epidermal penetration and dermal clearance.
    Siddiqui O; Roberts MS; Polack AE
    J Pharmacokinet Biopharm; 1989 Aug; 17(4):405-24. PubMed ID: 2614679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion modeling of percutaneous absorption kinetics. 1. Effects of flow rate, receptor sampling rate, and viable epidermal resistance for a constant donor concentration.
    Anissimov YG; Roberts MS
    J Pharm Sci; 1999 Nov; 88(11):1201-9. PubMed ID: 10564070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.